AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Novel screening assay to identify and evaluate drugs that target Familial and Sporadic Amyotrophic Lateral Scelrosis

Detailed Technology Description
In vitro cell-based assay thatenables investigating molecular disease mechanisms and evaluating potentialtherapies for Sporadic Amyotrophic Lateral Sclerosis (ALS).
Countries
Not Available
Application No.
None
*Abstract

This is an in vitro cell-based assay that enables investigating molecular disease mechanisms and evaluating potential therapies for Sporadic Amyotrophic Lateral Sclerosis (ALS). This assay utilizes human derived cells from individuals with the disease.

*Inquiry
Margaret Barkett, Ph.D.The Research Institute atNationwide Children's HospitalOffice of TechnologyCommercialization700 Children's DriveColumbus OH 43205T: 614 355-2957    F: 614722-2716Margaret.Barkett@nationwidechildrens.org
*IP Issue Date
None
*IP Type
Other Patent
Country/Region
USA

For more information, please click Here
Mobile Device